134
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Evolution of Peritoneal Dialysis-Associated Peritonitis: Pathogen, Antibiotic Resistance, and the Impact of Lymphocyte Count on Treatment Outcomes

ORCID Icon, ORCID Icon, , , , & show all
Pages 685-696 | Received 30 Sep 2023, Accepted 07 Feb 2024, Published online: 18 Feb 2024

References

  • Xia Y, Fan Q, Zhang J, et al. Risk factors and prognosis for latent tuberculosis infection in dialysis patients: a retrospective cohort study at a single tertiary care center. Semin Dial. 2023;37(1):59–64. doi:10.1111/sdi.13150
  • Yang Y, Liao Y, Yuan Z, Xiong Z, Xiong Z. Use of catheterography to diagnose a peritoneal dialysis catheter misplaced in the rectus sheath following percutaneous insertion. Perit Dial Int. 2020;40(5):518–519. doi:10.1177/0896860820918127
  • Liao JL, Zhang YH, Xiong ZB, et al. The Association of Cognitive Impairment with Peritoneal Dialysis-Related Peritonitis. Perit Dial Int. 2019;39(3):229–235. doi:10.3747/pdi.2018.00180
  • Hsieh YP, Chang CC, Wen YK, Chiu PF, Yang Y. Predictors of peritonitis and the impact of peritonitis on clinical outcomes of continuous ambulatory peritoneal dialysis patients in Taiwan--10 years’ experience in a single center. Perit Dial Int. 2014;34(1):85–94. doi:10.3747/pdi.2012.00075
  • Boudville N, Kemp A, Clayton P, et al. Recent peritonitis associates with mortality among patients treated with peritoneal dialysis. JASN is J Am Soc Nephrol. 2012;23(8):1398–1405. doi:10.1681/ASN.2011121135
  • Fan Q, Huang X, Zhang J, Sun Y, Xiong Z, Xiong Z. Value of gamma interferon enzyme-linked immunospot assay in the diagnosis of peritoneal dialysis-associated tuberculous peritonitis. Int Urol Nephrol. 2022;54(4):843–849. doi:10.1007/s11255-021-02960-1
  • Yang G, Tan L, Yao H, Xiong Z, Wu J, Huang X. Long-Term Effects of Severe Burns on the Kidneys: research Advances and Potential Therapeutic Approaches. J Inflamm Res. 2023;16:1905–1921. doi:10.2147/JIR.S404983
  • McGuire AL, Carson CF, Inglis TJ, Chakera A. Effects of a Statewide Protocol for the Management of Peritoneal Dialysis-Related Peritonitis on Microbial Profiles and Antimicrobial Susceptibilities: a Retrospective Five-Year Review. Perit Dial Int. 2015;35(7):722–728. doi:10.3747/pdi.2014.00117
  • Li PK, Chow KM, Cho Y, et al. ISPD peritonitis guideline recommendations: 2022 update on prevention and treatment. Perit Dial Int. 2022;42(2):110–153. doi:10.1177/08968608221080586
  • Ferri M, Ranucci E, Romagnoli P, Giaccone V. Antimicrobial resistance: a global emerging threat to public health systems. Crit Rev Food Sci Nutr. 2017;57(13):2857–2876. doi:10.1080/10408398.2015.1077192
  • Zeng Y, Jiang L, Lu Y, et al. Peritoneal dialysis-related peritonitis caused by gram-negative organisms: ten-years experience in a single center. Renal Failure. 2021;43(1):993–1003. doi:10.1080/0886022X.2021.1939050
  • Hwang TY, Kim MG, Oh SW, Jo SK, Cho WY, Yang J. Pathogens of peritoneal dialysis peritonitis: trends from a single-center experience over 15 years. Kidney Res Clin Pract. 2020;39(2):221–227. doi:10.23876/j.krcp.19.035
  • Kitterer D, Latus J, Pöhlmann C, Alscher MD, Kimmel M. Microbiological Surveillance of Peritoneal Dialysis Associated Peritonitis: antimicrobial Susceptibility Profiles of a Referral Center in Germany over 32 Years. PLoS One. 2015;10(9):e0135969. doi:10.1371/journal.pone.0135969
  • Yoon SY, Park HW, Kim HJ, et al. National trends in the prevalence of chronic kidney disease among Korean adults, 2007-2020. Sci Rep. 2023;13(1):5831. doi:10.1038/s41598-023-33122-1
  • Ademola AD, Asinobi AO, Alao MA, Olowu WA. Childhood Nephrotic Syndrome in Africa: epidemiology, Treatment Trends, and Outcomes. Semin Nephrol. 2023;42(5):151311. doi:10.1016/j.semnephrol.2023.151311
  • Wei YQ, Li XJ, Gao CL, Xia ZK. Research progress in growth of chronic kidney disease in children. Zhonghua Er Ke Za Zhi. 2023;61(5):474–477. doi:10.3760/cma.j.cn112140-20221104-00936
  • Yang Y, Da J, Jiang Y, Yuan J, Zha Y. Low serum parathyroid hormone is a risk factor for peritonitis episodes in incident peritoneal dialysis patients: a retrospective study. BMC Nephrol. 2021;22(1):44. doi:10.1186/s12882-021-02241-0
  • Wu H, Ye H, Huang R, et al. Incidence and risk factors of peritoneal dialysis-related peritonitis in elderly patients: a retrospective clinical study. Perit Dial Int. 2020;40(1):26–33. doi:10.1177/0896860819879868
  • Cao Y, Li W, Yang G, Liu Y, Li X. Diabetes and hypertension have become leading causes of CKD in Chinese elderly patients: a comparison between 1990-1991 and 2009-2010. Int Urol Nephrol. 2012;44(4):1269–1276. doi:10.1007/s11255-012-0194-0
  • Camargo CH, Cunha Mde L, Caramori JC, Mondelli AL, Montelli AC, Barretti P. Peritoneal dialysis-related peritonitis due to coagulase-negative Staphylococcus: a review of 115 cases in a Brazilian center. Clin J Am Soc Nephrol. 2014;9(6):1074–1081. doi:10.2215/CJN.09280913
  • Persy B, Ieven M. Four-year analysis of microbial aetiology and antimicrobial sensitivity patterns of peritoneal-dialysis related peritonitis in a tertiary care facility. Acta clinica Belgica. 2013;68(1):48–53. doi:10.2143/ACB.68.1.2062720
  • Szeto CC, Leung CB, Chow KM, et al. Change in bacterial aetiology of peritoneal dialysis-related peritonitis over 10 years: experience from a centre in South-East Asia. Clin Microbiol Infect. 2005;11(10):837–839. doi:10.1111/j.1469-0691.2005.01222.x
  • Wang HH, Huang CH, Kuo MC, et al. Microbiology of peritoneal dialysis-related infection and factors of refractory peritoneal dialysis related peritonitis: a ten-year single-center study in Taiwan. J. Microbiol Immunol Infect. 2019;52(5):752–759. doi:10.1016/j.jmii.2018.10.013
  • Yang G, Chen H, Chen Q, et al. Injury-induced interleukin-1 alpha promotes Lgr5 hair follicle stem cells de novo regeneration and proliferation via regulating regenerative microenvironment in mice. Inflamm Regen. 2023;43(1):14. doi:10.1186/s41232-023-00265-7
  • Yang G, Waheed S, Wang C, Shekh M, Li Z, Wu J. Exosomes and Their Bioengineering Strategies in the Cutaneous Wound Healing and Related Complications: current Knowledge and Future Perspectives. Int J Bio Sci. 2023;19(5):1430–1454. doi:10.7150/ijbs.80430
  • Ye P, Xie C, Wu C, et al. The application of metagenomic next-generation sequencing for detection of pathogens from dialysis effluent in peritoneal dialysis-associated peritonitis. Perit Dial Int. 2022;42(6):585–590. doi:10.1177/08968608221117315
  • Htay H, Cho Y, Pascoe EM, et al. Center Effects and Peritoneal Dialysis Peritonitis Outcomes: analysis of a National Registry. Am. J. Kidney Dis. 2018;71(6):814–821. doi:10.1053/j.ajkd.2017.10.017
  • Li PK, Szeto CC, Piraino B, et al. ISPD Peritonitis Recommendations: 2016 Update on Prevention and Treatment. Perit Dial Int. 2016;36(5):481–508. doi:10.3747/pdi.2016.00078
  • Saengsuwan P, Singkhamanan K, Madla S, Ingviya N, Romyasamit C. Molecular epidemiology of vancomycin-resistant Enterococcus faecium clinical isolates in a tertiary care hospital in southern Thailand: a retrospective study. PeerJ. 2021;9:e11478.
  • Zacharioudakis IM, Zervou FN, Ziakas PD, Rice LB, Mylonakis E. Vancomycin-resistant enterococci colonization among dialysis patients: a meta-analysis of prevalence, risk factors, and significance. Am J Kidney Dis. 2015;65(1):88–97. doi:10.1053/j.ajkd.2014.05.016
  • Moso MA, Macesic N. Peritoneal Dialysis-Related Peritonitis With Carbapenem-Resistant Klebsiella pneumoniae and Vancomycin-Resistant Enterococcus faecium. Open Forum Infect Dis. 2021;8(1). doi:10.1093/ofid/ofaa525
  • Jacoby GA, Munoz-Price LS. The new beta-lactamases. New Engl J Med. 2005;352(4):380–391. doi:10.1056/NEJMra041359
  • Leung CB, Szeto CC, Chow KM, et al. Cefazolin plus ceftazidime versus imipenem/cilastatin monotherapy for treatment of CAPD peritonitis--a randomized controlled trial. Perit Dial Int. 2004;24(5):440–446. doi:10.1177/089686080402400508
  • Wu H, Yi C, Zhang D, et al. Changes of antibiotic resistance over time among Escherichia coli peritonitis in Southern China. Perit Dial Int. 2022;42(2):218–222. doi:10.1177/08968608211045272
  • Malloy AM, Campos JM. Extended-spectrum beta-lactamases: a brief clinical update. Pediatr Infect Dis J. 2011;30(12):1092–1093. doi:10.1097/INF.0b013e31823c0e9d
  • Yip T, Tse KC, Lam MF, et al. Risk factors and outcomes of extended-spectrum beta-lactamase-producing E. coli peritonitis in CAPD patients. Perit Dial Int. 2006;26(2):191–197. doi:10.1177/089686080602600213
  • Xu H, Zhong L, Deng J, et al. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int J Oral Sci. 2020;12(1):8. doi:10.1038/s41368-020-0074-x
  • Singh S, Sharma A, Arora SK. High producer haplotype (CAG) of −863C/A, −308G/A and −238G/A polymorphisms in the promoter region of TNF-α gene associate with enhanced apoptosis of lymphocytes in HIV-1 subtype C infected individuals from North India. PLoS One. 2014;9(5):56.
  • Liao YC, Liang WG, Chen FW, Hsu JH, Yang JJ, Chang MS. IL-19 induces production of IL-6 and TNF-alpha and results in cell apoptosis through TNF-alpha. J Iimmunol. 2002;169(8):4288–4297. doi:10.4049/jimmunol.169.8.4288
  • Aggarwal S, Gollapudi S, Gupta S. Increased TNF-alpha-induced apoptosis in lymphocytes from aged humans: changes in TNF-alpha receptor expression and activation of caspases. J Iimmunol. 1999;162(4):2154–2161. doi:10.4049/jimmunol.162.4.2154
  • Chan JF, Zhang AJ, Yuan S, et al. Simulation of the Clinical and Pathological Manifestations of Coronavirus Disease 2019 (COVID-19) in a Golden Syrian Hamster Model: implications for Disease Pathogenesis and Transmissibility. Clin Infect Dis. 2020;71(9):2428–2446. doi:10.1093/cid/ciaa644
  • Cronkite DA, Strutt TM. The Regulation of Inflammation by Innate and Adaptive Lymphocytes. J Immunol Res. 2018;2018(2018):1467538. doi:10.1155/2018/1467538
  • Hu J, Kang H, Liu C, Hu P, Yang M, Zhou F. Regulatory T Cells Could Improve Intestinal Barrier Dysfunction in Heatstroke. Inflammation. 2019;42(4):1228–1238. doi:10.1007/s10753-019-00983-6
  • Powell N, MacDonald TT. Recent advances in gut immunology. Parasite Immunol. 2017;39(6). doi:10.1111/pim.12430
  • Park A, Lee Y, Kim MS, et al. Prostaglandin E2 Secreted by Thyroid Cancer Cells Contributes to Immune Escape Through the Suppression of Natural Killer (NK) Cell Cytotoxicity and NK Cell Differentiation. Front Immunol. 2018;9:1859. doi:10.3389/fimmu.2018.01859